Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bi-citrate
2. Biselic
3. Bismofarma
4. Bismuth Subcitrate
5. Bismuth Tripotassium Dicitrate
6. Colloidal Bismuth Subcitrate
7. De-nol
8. De-noltab
9. Denol
10. Gastrodenol
11. Sucrato
12. Tripotassium-dicitrato Bismuthate
13. Ventrisol-polfa
1. 813-93-4
2. Bismuth(iii) Citrate
3. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt (1:1)
4. N04867y76n
5. Bismuth Citrate [usp:usp]
6. Bi-citrate
7. Unii-n04867y76n
8. Einecs 212-390-1
9. Bismuth Citrate (usp)
10. Ec 212-390-1
11. Tegokat 752
12. Schembl41916
13. Bismuth, (citrato(3-))-
14. Bismuth Citrate [inci]
15. Citric Acid Bismuth(iii) Salt
16. Bismuth Citrate [mart.]
17. Dtxsid6074330
18. Bismuth Citrate [usp-rs]
19. Bismuth Citrate [who-dd]
20. Chebi:157700
21. Mfcd00050817
22. Akos015839589
23. Bismuth Citrate [usp Monograph]
24. D08875
25. Bismuth(3+) 2-hydroxypropane-1,2,3-tricarboxylate
26. 2-hydroxy-1,2,3-propanetricarboxylic Acid Bismuth Salt
27. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth (3+) Salt (1:1)
Molecular Weight | 398.08 g/mol |
---|---|
Molecular Formula | C6H5BiO7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 397.98393 g/mol |
Monoisotopic Mass | 397.98393 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Antacids
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?